Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dide den Hollander

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Critical Reviews in Oncology/Hematology|June 29, 2015
Pretreatment body mass index and head and neck cancer outcome: A review of the literatureDide den Hollander, Ellen Kampman, Carla M L van Herpen
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 1, 2020
The complexity of assessing health-related quality of life among sarcoma patientsOlga Husson, Dide den Hollander, Winette T A van der Graaf
ESMO Open|October 21, 2020
Unravelling the heterogeneity of soft tissue and bone sarcoma patients' health-related quality of life: a systematic literature review with focus on tumour locationDide den Hollander, Winette T A Van der Graaf, Marco Fiore, et al.
Targeted Oncology|April 20, 2023
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry DataMahmoud Mohammadi, Nikki S IJzerman, Dide den Hollander, et al.
Targeted Oncology|November 14, 2022
Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST PatientsMahmoud Mohammadi, Thekla M Jansen-Werkhoven, Nikki S Ijzerman, et al.
Cancers|April 12, 2022
Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the LiteratureDeborah van de Wal, Mai Elie, Axel Le Cesne, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 9, 2024
Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre studyDeborah van de Wal, Dide den Hollander, Ingrid M E Desar, et al.
International Journal of Clinical and Health Psychology : IJCHP|January 16, 2024
Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter studyDeborah van de Wal, Dide den Hollander, Ingrid M E Desar, et al.
Health and Quality of Life Outcomes|April 21, 2022
'I thought I had fibroids, and now I don't': a mixed method study on health-related quality of life in uterine sarcoma patientsDide den Hollander, Emma Lidington, Susanne Singer, et al.
Acta Oncologica (Stockholm, Sweden)|October 19, 2023
The association of having a monitoring or blunting coping style with psychological distress, health-related quality of life and satisfaction with healthcare in gastrointestinal stromal tumour (GIST) patientsDeborah van de Wal, Britt van Doorn, Dide den Hollander, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|June 29, 2015
Pretreatment body mass index and head and neck cancer outcome: A review of the literatureDide den Hollander, Ellen Kampman, Carla M L van Herpen
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 1, 2020
The complexity of assessing health-related quality of life among sarcoma patientsOlga Husson, Dide den Hollander, Winette T A van der Graaf
ESMO Open|October 21, 2020
Unravelling the heterogeneity of soft tissue and bone sarcoma patients' health-related quality of life: a systematic literature review with focus on tumour locationDide den Hollander, Winette T A Van der Graaf, Marco Fiore, et al.
Targeted Oncology|April 20, 2023
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry DataMahmoud Mohammadi, Nikki S IJzerman, Dide den Hollander, et al.
Targeted Oncology|November 14, 2022
Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST PatientsMahmoud Mohammadi, Thekla M Jansen-Werkhoven, Nikki S Ijzerman, et al.
Cancers|April 12, 2022
Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the LiteratureDeborah van de Wal, Mai Elie, Axel Le Cesne, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 9, 2024
Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre studyDeborah van de Wal, Dide den Hollander, Ingrid M E Desar, et al.
International Journal of Clinical and Health Psychology : IJCHP|January 16, 2024
Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter studyDeborah van de Wal, Dide den Hollander, Ingrid M E Desar, et al.
Health and Quality of Life Outcomes|April 21, 2022
'I thought I had fibroids, and now I don't': a mixed method study on health-related quality of life in uterine sarcoma patientsDide den Hollander, Emma Lidington, Susanne Singer, et al.
Acta Oncologica (Stockholm, Sweden)|October 19, 2023
The association of having a monitoring or blunting coping style with psychological distress, health-related quality of life and satisfaction with healthcare in gastrointestinal stromal tumour (GIST) patientsDeborah van de Wal, Britt van Doorn, Dide den Hollander, et al.
Pageof 2